NIH-funded research R01 grant

Personalized grafts for treating thoracic aortic aneurysms caused by genetics

Official title: Towards Personalized Prosthetic Graft Replacement for Genetically Triggered Thoracic Aortic Aneurysms

Funded at Weill Medical Coll of Cornell Univ · NIH-10878897 · Data updated 2026-11-12

This study is looking at how to make better, personalized grafts for people with thoracic aortic aneurysms to help reduce complications after surgery, especially for those who are genetically at risk, by using advanced imaging to understand their unique needs.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 1, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$691,821
NIH project number5R01HL170570-02
Project IDNIH-10878897 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with genetically triggered thoracic aortic aneurysms who may require surgical intervention.

Less likely to help

Patients with thoracic aortic aneurysms not caused by genetic factors may not benefit from this research.

What this research studies

This research focuses on improving the treatment of thoracic aortic aneurysms (TAA) by developing personalized prosthetic grafts. It aims to address the increased risk of complications, particularly downstream dissections, that genetically predisposed patients face after standard graft replacement. The approach involves identifying specific markers of disease progression in the aorta after surgery, utilizing advanced imaging techniques like 4D flow MRI to monitor changes in aortic stiffness and blood flow dynamics. By tailoring grafts to individual patient needs, the goal is to enhance safety and outcomes for those affected by TAA.

Why it matters

Potential benefit: If successful, this research could significantly reduce the risk of life-threatening complications for patients with genetically triggered thoracic aortic aneurysms.

How similar studies have gone: Previous research has shown promising results in using advanced imaging techniques to monitor aortic conditions, suggesting that this approach could lead to significant advancements in treatment.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Weinsaft, Jonathan W. — Weill Medical Coll of Cornell Univ
  • Study coordinator: Weinsaft, Jonathan W.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.